Breast cancer risk reduced in those who take hormone therapy in moderation
Posted on 09. Nov, 2009 by Turbo in Health
According to researchers, if hormone therapy (post-menopausal) is taken in moderation there is a reduced risk of atypical ductal hyperplasia which could be a risk factor for malignancy of breasts.
According to Dr. Tehillah Menes, Dept of Surgery, Elmhurst Hospital Center, NY, post-menopausal treatment with hormones has found correlation with with benign breast hyperplasias, early as well as late stages of breast cancer.
She further adds that atypical ductal hyperplasia and post-menopausal hormonal therapy are associated and the risk rates have dropped when there is a reduction in use of hormonal therapy.
The findings will assist in clarifying the various pathways that lead to development of breast cancer, and also how post-menopausal hormone therapy will affect in increasing the risk rates of the cancer.
